MRKR Cash from Financing Activities - Cash Flow Statement - Marker Therapeutics, Inc. - IntrinsicAlpha

Marker Therapeutics, Inc. MRKR

Healthcare - Biotechnology - NASDAQ - US

$ 1.5547

1.61 %

$ 16.6 M

Market Cap

-1.45

P/E

MRKR - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities MRKR - Marker Therapeutics, Inc.

1.11 M

LAST VALUE

-85.50%

2 YEAR CAGR

-56.54%

5 YEAR CAGR

4.53%

10 YEAR CAGR